Page last updated: 2024-10-25

dantrolene and Leukocytosis

dantrolene has been researched along with Leukocytosis in 2 studies

Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.

Leukocytosis: A transient increase in the number of leukocytes in a body fluid.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kajani, R1
Apramian, A1
Vega, A1
Ubhayakar, N1
Xu, P1
Liu, A1
Shalev, A1
Munitz, H1

Reviews

1 review available for dantrolene and Leukocytosis

ArticleYear
The neuroleptic malignant syndrome: agent and host interaction.
    Acta psychiatrica Scandinavica, 1986, Volume: 73, Issue:4

    Topics: Adolescent; Adult; Aftercare; Aged; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antip

1986

Other Studies

1 other study available for dantrolene and Leukocytosis

ArticleYear
Neuroleptic malignant syndrome in a COVID-19 patient.
    Brain, behavior, and immunity, 2020, Volume: 88

    Topics: Acute Kidney Injury; Antipsychotic Agents; Betacoronavirus; Bromocriptine; C-Reactive Protein; Coron

2020